Skip to content
SSDP/Country guide

🇬🇧 United Kingdom

Misuse of Drugs Act; devolved harm reduction leadership.

EuropeNo chapter yetDetailed profile

Legal context

European countries vary widely, from decriminalisation and diversion models to criminal penalties, with growing debate on cannabis regulation and health-led responses.

Health response (HRI 2024)

Harm Reduction International (2024) reports at least one operational service in United Kingdom: needle & syringe programmes, opioid agonist therapy, take-home naloxone, peer naloxone distribution, safer smoking kits. Inside prisons: OAT. National policy documents include an explicit supportive reference to harm reduction.

Youth leadership

Youth participation often happens through civil-society coalitions, student movements, municipal consultations and European-level advocacy networks.

Misuse of Drugs Act; devolved harm reduction leadership.

Drug policy briefing

What young people should know about drug policy in United Kingdom

Decriminalisation

Criminalised, cautions used

Personal possession is criminal under the Misuse of Drugs Act 1971. Diversion schemes operate in several police areas.

Evidence · Misuse of Drugs Act 1971; ACMD reports.

Harm Reduction

Publicly funded, uneven

Needle exchange, OAT, naloxone and drug-checking pilots operate across the UK, with Scotland pursuing more expansive harm reduction.

Evidence · OHID; Public Health Scotland.

Youth Participation

Advisory, growing

Youth advisory groups contribute to ACMD, OHID and devolved government consultations.

Evidence · SSDP UK; Release; ACMD.

Treatment Systems

NHS-funded

Treatment is publicly funded through the NHS with community and residential options; commissioning varies by locality.

Evidence · OHID; NHS.

Sources · Harm Reduction International, Global State of Harm Reduction 2024 · UNODC · WHO · EMCDDA/EUDA · national laws and civil-society monitoring. Last reviewed Harm Reduction International 2024.